Peregrine Pharmaceuticals, Inc. – Trademark Portfolio
Entity Type: 03
Peregrine Pharmaceuticals, Inc. holds 19 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 14 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 4 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include AVID BIOSERVICES. The owner is based in Princeton, NJ.
1 Palmer Square
Suite 530
Princeton, NJ 08542
Showing of trademarks Trademarks
Trademark Classifications
Peregrine Pharmaceuticals, Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does Peregrine Pharmaceuticals, Inc. have?
Peregrine Pharmaceuticals, Inc. has 19 U.S. trademarks filed with the USPTO. Of these, 2 registered, 10 abandoned, 7 cancelled.
What trademark classes does Peregrine Pharmaceuticals, Inc. file in?
Peregrine Pharmaceuticals, Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 40 (Treatment & Processing), Class 1 (Chemicals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Peregrine Pharmaceuticals, Inc.'s most well-known trademarks?
Peregrine Pharmaceuticals, Inc.'s registered trademark portfolio includes well-known marks such as AVID BIOSERVICES. These are among 2 currently registered trademarks in the portfolio.
What is Peregrine Pharmaceuticals, Inc.'s trademark registration success rate?
Peregrine Pharmaceuticals, Inc. has a 11% trademark registration rate, with 2 out of 19 resolved applications resulting in successful registration. Currently, 0 applications are pending review.